Vitiligo Vulgaris Clinical Trial
Official title:
Demographic and Laboratory Data Collection for Patients With Vitiligo Vulgaris
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo. ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00907062 -
Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
|
Phase 1 | |
Completed |
NCT00372307 -
Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris
|
Phase 2 | |
Completed |
NCT01401374 -
Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
|
N/A | |
Not yet recruiting |
NCT03234673 -
The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo
|
Phase 1 |